Venus Concept, Inc. (VERO)
0.3105
0.00 (0.00%)
USD |
OTCM |
Apr 07, 16:00
Venus Concept Shareholders Equity (Quarterly) : 2.673M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 2.673M |
| June 30, 2025 | 2.327M |
| March 31, 2025 | 2.262M |
| December 31, 2024 | 2.369M |
| September 30, 2024 | 10.11M |
| June 30, 2024 | 3.702M |
| March 31, 2024 | -22.49M |
| December 31, 2023 | -14.02M |
| September 30, 2023 | -12.17M |
| June 30, 2023 | -6.222M |
| March 31, 2023 | -0.886M |
| December 31, 2022 | 8.093M |
| September 30, 2022 | 9.345M |
| June 30, 2022 | 22.84M |
| March 31, 2022 | 32.79M |
| December 31, 2021 | 40.94M |
| September 30, 2021 | 28.05M |
| June 30, 2021 | 37.63M |
| Date | Value |
|---|---|
| March 31, 2021 | 36.60M |
| December 31, 2020 | 44.23M |
| September 30, 2020 | 35.58M |
| June 30, 2020 | 39.18M |
| March 31, 2020 | 44.80M |
| December 31, 2019 | 74.18M |
| September 30, 2019 | -21.80M |
| June 30, 2019 | -12.98M |
| March 31, 2019 | -5.474M |
| December 31, 2018 | 32.43M |
| September 30, 2018 | 9.313M |
| June 30, 2018 | 0.603M |
| March 31, 2018 | 6.088M |
| December 31, 2017 | 13.19M |
| September 30, 2017 | -14.04M |
| June 30, 2017 | -7.574M |
| March 31, 2017 | -12.93M |
| December 31, 2016 | -7.809M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hypertension Diagnostics, Inc. | -- |
| Avitar, Inc. | -- |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 61.62M |
| Total Liabilities (Quarterly) | 58.49M |